Table 1 The baseline characteristics of the 26 eligible patients in this study

Age

Median (min–max)

39 (16–70)

Gender—male

N (%)

11(42.3)

Body weight, kg

Median (min–max)

51.9 (37.7–87.7)

Duration of disease, month

Median (min–max)

58 (10–159)

Extent of UC (Montreal classification)

Left side colitis (E2)

N

10

Pancolitis (E3)

N

16

Disease activity

pMayo score

Median (IQR)

6 (5.25–7)

MES

Median (IQR)

2 (2–2)

Concomitant medication

5-aminosalicylic acid

N (%)

23 (88.4)

Corticosteroid

N (%)

8 (30.7)

Immunosuppressant

N (%)

11 (42.3)

Anti-TNF-alpha agent

N (%)

5 (19.2)

Biomarker

FC (mg/kg)

Median (IQR)

11,294.5 (5116.75–18,755.25)

WBC count

Median (IQR)

6350 (4935–7945)

CRP (mg/dL)

Median (IQR)

0.58 (0.1–1.39)